NASDAQ:LMAT

LeMaitre Vascular Earnings Date, Estimates & History

$50.49
+0.42 (+0.84 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$50.13
Now: $50.49
$50.86
50-Day Range
$45.69
MA: $48.57
$51.50
52-Week Range
$23.40
Now: $50.49
$54.96
Volume76,819 shs
Average Volume125,315 shs
Market Capitalization$1.04 billion
P/E Ratio54.29
Dividend Yield0.88%
Beta1.43

Earnings

LeMaitre Vascular (NASDAQ:LMAT) Earnings Information

LeMaitre Vascular last posted its earnings data on February 25th, 2021. The medical instruments supplier reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.03. The business had revenue of $37.55 million for the quarter, compared to analyst estimates of $35.87 million. LeMaitre Vascular has generated $0.88 earnings per share over the last year and currently has a price-to-earnings ratio of 54.3. LeMaitre Vascular has confirmed that its next quarterly earnings report will be published on Thursday, April 29th, 2021. LeMaitre Vascular will be holding an earnings conference call on Thursday, April 29th. Interested parties can register for or listen to the call using this link.

LeMaitre Vascular Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LeMaitre Vascular (NASDAQ:LMAT) Earnings Estimates

2021 EPS Consensus Estimate: $0.90
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20211$0.28$0.28$0.28
Q3 20211$0.30$0.30$0.30
Q4 20211$0.32$0.32$0.32
Q1 20221$0.30$0.30$0.30
Q2 20221$0.32$0.32$0.32
Q4 20221$0.38$0.38$0.38

LeMaitre Vascular (NASDAQ LMAT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/29/2021
(Confirmed)
 $0.28    Register (After Market Closes)
2/25/202112/31/2020$0.31$0.34$0.34$35.87 million$37.55 millionTranscript
10/29/20209/30/2020$0.19$0.37$0.37$31.62 million$36.42 millionListen
7/23/20206/30/2020$0.01$0.17$0.17$15.58 million$24.85 millionTranscript
4/30/2020Q1 2020$0.16$0.16$0.16$30.50 million$30.55 millionTranscript
2/6/2020Q4 2019$0.23$0.23$0.23$30.44 million$30.20 millionTranscript
10/23/2019Q3$0.21$0.25$0.25$28.15 million$29.10 millionTranscript
7/24/2019Q2$0.21$0.23$0.23$28.90 million$29.48 millionListen
5/1/20193/31/2019$0.19$0.17$0.17$27.94 million$28.48 millionN/A
2/19/201912/31/2018$0.24$0.24$0.18$26.06 million$28.39 millionListen
10/5/2018Q3 2018$0.2070$0.2090$0.21$26.06 million$24.17 millionN/A
7/26/2018Q2 2018$0.42$0.21$0.43$27.09 million$27.02 millionTranscript
4/25/2018Q1 2018$0.21$0.19$0.19$26.42 million$25.99 millionN/A
2/21/2018Q4 2017$0.20$0.21$0.21$26.23 million$26.15 millionTranscript
10/26/2017Q3 2017$0.20$0.25$0.25$25.49 million$24.80 millionN/A
7/27/2017Q2 2017$0.17$0.23$0.23$25.42 million$25.80 millionN/A
5/4/2017Q1 2017$0.1310$0.16$0.16$23.48 million$24.10 millionN/A
4/26/2017Q1 2017$0.13$0.16$0.16$23.50 million$24.14 millionN/A
2/21/2017Q4 2016$0.15$0.13$0.13$23.70 million$23.30 millionListen
10/26/2016Q3$0.15$0.17$0.17$22.20 million$19.00 millionListen
7/27/2016Q2$0.11$0.14$0.14$21.59 million$22.40 millionListen
5/2/2016Q1$0.10$0.11$0.11$20.22 million$20.26 millionListen
2/24/2016Q415$0.09$0.13$0.13$20.10 million$20.50 millionListen
10/27/2015Q3$0.0780$0.11$0.11$18.78 million$19.03 millionListen
7/28/2015Q2$0.07$0.10$0.10$18.90 million$19.90 millionListen
4/28/2015Q115$0.05$0.08$0.08$17.76 million$18.90 millionListen
2/25/2015Q314$0.07$0.11$0.11$18.90 million$18.70 millionListen
10/28/2014Q3$0.06$0.05$0.05$17.09 million$17.50 millionListen
7/29/2014Q2 2014$0.05$0.09$0.10$17.57 million$18.16 millionN/A
4/29/2014Q1 2014$0.02$0.02$0.05$16.99 million$16.75 millionN/A
2/25/2014Q4 2013$0.06$0.05$0.05$16.45 million$17.92 millionListen
10/29/2013Q3 2013$0.05$0.05$0.05$15.22 million$15.30 millionListen
7/30/2013Q2 2013$0.04$0.06$0.06$15.42 million$15.95 millionN/A
4/30/2013Q1 2013($0.01)$0.05$0.05$15.00 million$15.38 millionN/A
2/26/2013Q4 2012$0.06$0.03$0.02N/A
10/30/2012Q3 2012$0.04$0.04$0.04N/A
7/31/2012Q2 2012$0.04$0.05$0.05N/A
5/2/2012Q1 2012$0.04$0.02$0.02N/A
2/27/2012Q4 2011$0.06$0.03$0.04N/A
10/27/2011Q3 2011$0.08$0.06$0.04N/A
7/28/2011Q2 2011$0.09$0.06$0.09N/A
4/28/2011Q1 2011$0.06$0.05$0.10N/A
2/28/2011Q4 2010$0.25$0.37N/A
10/28/2010Q3 2010$0.08$0.09$0.09N/A
7/28/2010Q2 2010$0.06$0.09$0.09N/A
4/29/2010Q1 2010$0.05$0.06$0.06N/A
3/4/2010Q4 2009$0.08$0.08N/A
10/28/2009Q3 2009$0.08$0.08N/A
7/29/2009Q2 2009$0.03$0.06$0.06N/A
4/28/2009Q1 2009($0.17)($0.04)$0.04N/A
3/3/2009Q4 2008$0.03$0.04N/A
10/29/2008Q3 2008($0.02)($0.01)($0.01)N/A
7/29/2008Q2 2008($0.04)($0.04)($0.02)N/A
4/30/2008Q1 2008($0.07)($0.12)($0.07)N/A
3/4/2008Q4 2007($0.03)($0.05)($0.02)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.